Company Filing History:
Years Active: 2025
Title: Innovations by Shuoyu Xu in Colorectal Cancer Treatment
Introduction
Shuoyu Xu is a notable inventor based in Guangdong, China. He has made significant contributions to the field of cancer treatment, particularly in predicting the efficacy of immunotherapy for colorectal cancer. His innovative approach combines advanced imaging techniques with algorithmic analysis to enhance patient outcomes.
Latest Patents
Shuoyu Xu holds a patent for a "System for predicting immunotherapeutic efficacy for colorectal cancer." This system performs several operations, including obtaining a digital image of biological tissue from a colorectal cancer patient. It predicts tissue type and cell type parameters using a classifier algorithm model. Additionally, it determines various cell feature parameters based on a calculating rule and calculates a therapeutic efficacy score. This score is designed to predict the therapeutic efficacy of immunotherapy for colorectal cancer patients.
Career Highlights
Shuoyu Xu is affiliated with the Sun Yat-sen University Cancer Center, where he conducts research and develops innovative solutions for cancer treatment. His work is instrumental in advancing the understanding of how immunotherapy can be tailored to individual patients based on their unique biological characteristics.
Collaborations
Shuoyu Xu collaborates with esteemed colleagues, including Peirong Ding and Wu Jiang. Their combined expertise contributes to the ongoing research and development of effective cancer therapies.
Conclusion
Shuoyu Xu's innovative work in predicting immunotherapeutic efficacy represents a significant advancement in colorectal cancer treatment. His contributions are paving the way for more personalized and effective cancer therapies, ultimately improving patient care.